T315I MUTATION TREATMENT Trademark

Trademark Overview

On Friday, January 15, 2021, a trademark application was filed for T315I MUTATION TREATMENT with the United States Patent and Trademark Office. The USPTO has given the T315I MUTATION TREATMENT trademark a serial number of 90468896. The federal status of this trademark filing is REGISTERED as of Tuesday, September 2, 2025. This trademark is owned by Paladin Labs Inc.. The T315I MUTATION TREATMENT trademark is filed in the Computer & Software Services & Scientific Services and Medical & Beauty Services & Agricultural Services categories with the following description:

Medical testing for diagnostic and prognostic purposes in the field of cancer, kinase inhibitor treatment failure, and genetics; Medical testing for diagnostic and treatment purposes in the field of cancer research, kinase inhibitor treatment failure research, and genetics research; Providing medical information to medical professionals, namely, oncologists and treating physicians for cancer patients, in the form of reports in the field of cancer diagnostics and prognostics; Medical testing services, namely, kinase inhibitor treatment failure and genetic testing for diagnosis and treatment of cancer; Genetic testing for medical purposes

Providing scientific analysis and informational reports based upon results of laboratory testing in the field of kinase inhibitor treatment failure, genetics, epigenetics and cancer; Scientific research in the fields of kinase inhibitor treatment failure, genetics, epigenetics and cancer; Laboratory research in the field of the field of cancer research, kinase inhibitor treatment failure, and genetics; Providing laboratory research services in the field of kinase inhibitor treatment failure and genetic testing
t315i mutation treatment

General Information

Serial Number90468896
Word MarkT315I MUTATION TREATMENT
Filing DateFriday, January 15, 2021
Status700 - REGISTERED
Status DateTuesday, September 2, 2025
Registration Number7924289
Registration DateTuesday, September 2, 2025
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, July 15, 2025

Trademark Statements

Description of MarkThe mark consists of grey letters and numbers for "T315I" with the "3" being a swirl design where the outside is purple and the inside is orange and the words "MUTATION TREATMENT" are in purple title case letters with a purple plus sign in front of these words.
Pseudo MarkT THREE ONE FIVE ONE; T THREE ONE FIFTY ONE
Indication of Colors claimedThe color(s) grey, purple and orange is/are claimed as a feature of the mark.
Goods and ServicesMedical testing for diagnostic and prognostic purposes in the field of cancer, kinase inhibitor treatment failure, and genetics; Medical testing for diagnostic and treatment purposes in the field of cancer research, kinase inhibitor treatment failure research, and genetics research; Providing medical information to medical professionals, namely, oncologists and treating physicians for cancer patients, in the form of reports in the field of cancer diagnostics and prognostics; Medical testing services, namely, kinase inhibitor treatment failure and genetic testing for diagnosis and treatment of cancer; Genetic testing for medical purposes
NOT AVAILABLE"T315I MUTATION TREATMENT"
Goods and ServicesProviding scientific analysis and informational reports based upon results of laboratory testing in the field of kinase inhibitor treatment failure, genetics, epigenetics and cancer; Scientific research in the fields of kinase inhibitor treatment failure, genetics, epigenetics and cancer; Laboratory research in the field of the field of cancer research, kinase inhibitor treatment failure, and genetics; Providing laboratory research services in the field of kinase inhibitor treatment failure and genetic testing

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, April 16, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, April 16, 2021
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameENDO OPERATIONS LIMITED
Party Type30 - Original Registrant
Legal Entity Type24 - NOT AVAILABLE
AddressBALLSBRIDGE 4
IE
Party NameENDO OPERATIONS LIMITED
Party Type20 - Owner at Publication
Legal Entity Type24 - NOT AVAILABLE
AddressBALLSBRIDGE 4
IE
Party NameENDO OPERATIONS LIMITED
Party Type11 - New Owner Before Publication
Legal Entity Type24 - NOT AVAILABLE
AddressBALLSBRIDGE 4
IE
Party NamePaladin Labs Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSt-Laurent, Quebec H4M2P2
CA

Trademark Events

Event DateEvent Description
Tuesday, January 19, 2021NEW APPLICATION ENTERED
Wednesday, April 14, 2021ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Friday, April 16, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, April 17, 2021NOTICE OF DESIGN SEARCH CODE E-MAILED
Tuesday, July 27, 2021ASSIGNED TO EXAMINER
Monday, August 16, 2021NON-FINAL ACTION WRITTEN
Monday, August 16, 2021NON-FINAL ACTION E-MAILED
Monday, August 16, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, August 17, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, August 17, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, August 18, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, October 27, 2021SUSPENSION LETTER WRITTEN
Wednesday, October 27, 2021LETTER OF SUSPENSION E-MAILED
Wednesday, October 27, 2021NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, June 1, 2022SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Tuesday, June 21, 2022SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Wednesday, June 22, 2022SUSPENSION INQUIRY WRITTEN
Wednesday, June 22, 2022INQUIRY TO SUSPENSION E-MAILED
Wednesday, June 22, 2022NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Friday, June 24, 2022TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Sunday, July 10, 2022ASSIGNED TO LIE
Monday, July 11, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, July 11, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, July 29, 2022EXAMINERS AMENDMENT -WRITTEN
Wednesday, August 24, 2022SUSPENSION LETTER WRITTEN
Friday, July 29, 2022EXAMINERS AMENDMENT E-MAILED
Friday, July 29, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, July 29, 2022EXAMINER'S AMENDMENT ENTERED
Wednesday, August 24, 2022LETTER OF SUSPENSION E-MAILED
Wednesday, August 24, 2022NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Thursday, August 25, 2022TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Friday, August 26, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, August 26, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, September 7, 2022SUSPENSION LETTER WRITTEN
Wednesday, September 7, 2022LETTER OF SUSPENSION E-MAILED
Wednesday, September 7, 2022NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Thursday, April 6, 2023SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Thursday, June 8, 2023SUSPENSION LETTER WRITTEN
Thursday, June 8, 2023LETTER OF SUSPENSION E-MAILED
Thursday, June 8, 2023NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Friday, June 9, 2023TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Saturday, June 10, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, June 10, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Sunday, August 20, 2023SUSPENSION LETTER WRITTEN
Sunday, August 20, 2023LETTER OF SUSPENSION E-MAILED
Sunday, August 20, 2023NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Thursday, May 23, 2024SUSPENSION INQUIRY WRITTEN
Wednesday, February 21, 2024SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Wednesday, May 1, 2024AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Friday, May 3, 2024SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Thursday, May 23, 2024NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Thursday, May 23, 2024INQUIRY TO SUSPENSION E-MAILED
Monday, June 17, 2024SUSPENSION LETTER WRITTEN
Friday, May 24, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, May 24, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, May 24, 2024TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Monday, June 17, 2024LETTER OF SUSPENSION E-MAILED
Monday, June 17, 2024NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Friday, June 28, 2024ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Tuesday, February 4, 2025SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Wednesday, February 12, 2025INQUIRY TO SUSPENSION E-MAILED
Wednesday, February 12, 2025SUSPENSION INQUIRY WRITTEN
Wednesday, February 12, 2025NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Friday, April 11, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, April 11, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Saturday, April 19, 2025NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Tuesday, April 8, 2025TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Saturday, April 19, 2025LETTER OF SUSPENSION E-MAILED
Saturday, April 19, 2025SUSPENSION LETTER WRITTEN
Monday, June 2, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, June 2, 2025TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Friday, June 13, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, July 9, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 15, 2025PUBLISHED FOR OPPOSITION
Tuesday, July 15, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 2, 2025REGISTERED-PRINCIPAL REGISTER
Tuesday, September 2, 2025NOTICE OF REGISTRATION CONFIRMATION EMAILED
Monday, June 2, 2025TEAS/EMAIL CORRESPONDENCE ENTERED

Related Keywords

treatment mutation cancer kinase inhibitor failure field testing research medical genetics